动脉样硬化的干细胞增殖加速了克隆造血
Alexander Heyde1, David Rohde2, Cameron S McAlpine2
1Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Cell
|February 26, 2021
概括
增加的造血干细胞增殖加速克隆造血,增加心血管疾病的风险. 这项研究显示动脉样硬化患者的干细胞分裂率升高,这解释了这一关联的很大一部分.
科学领域:
- 血液学
- 心血管科学
- 遗传学
背景情况:
- 克隆造血,突变造血干细胞克隆的扩张,与心血管疾病 (CVD) 有关.
- 连接克隆造血和心血管疾病的机制尚不清楚.
研究的目的:
- 研究血造干细胞 (HSC) 增殖在心血管疾病和克隆血造之间的关联中的作用.
- 确定增加的HSC分裂率是否有助于动脉样硬化中的克隆扩张.
主要方法:
- 在患有动脉样硬化的小鼠和人类中测量HSC分裂率.
- 开发了一个数学模型来评估扩散对克隆进化的影响.
- 使用动脉样硬化和睡眠碎片化的小鼠模型进行验证的结果.
主要成果:
- 动脉样硬化患者和小鼠的HSC分裂率较高.
- 数学模型显示增加的增殖加速了体质进化和克隆扩张.
- 患者的分裂率升高预测到70岁时,克隆造血的风险增加3. 5倍.
- 在升高的造血活性条件下观察到 Tet2- / - HSC 的加速扩张.
结论:
- 增加的HSC增殖是动脉样硬化和克隆造血之间的关键机制.
- 在心血管疾病的背景下,增加的干细胞分裂率显著增加了克隆造血的风险.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Atherosclerosis I: Introduction
355
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
355
Hematopoiesis
7.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.7K
Production of Formed Elements
3.0K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.0K
Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K


